CANNABIS NEWZ
The Wire / Regulation
REGULATIONWashington

DEA approvals could unlock tax benefits for Washington medical marijuana businesses

Potential federal rescheduling opens door to Section 280E tax relief for state-licensed medical cannabis operators.

The Cannabis Newz Automated Desk
Machine-written from our data · source: WTOP News
October 30, 2026 · 7:00 AM ET
Interior dome of a state capitol buildingFILE — statehouse · B.D. Gilfry / CC BY-SA 2.0
Interior dome of a state capitol building — file photo, not the scene of this story.

According to WTOP News, DEA approvals could bring tax benefits to Washington's medical marijuana businesses. The timing aligns with Washington state's October regulatory adjustments to comply with federal rescheduling, per MJBizDaily, suggesting the state has already begun positioning operators for potential federal relief.

Section 280E of the Internal Revenue Code has historically barred cannabis businesses from deducting ordinary operating expenses. A lower federal schedule classification could allow medical operators to claim standard business deductions—a significant cost reduction for licensed producers and retailers. Washington currently operates 482 retail locations, 973 cultivation facilities, and 1,009 manufacturing licenses, per state records.

Watch whether the Washington Liquor & Cannabis Board issues formal guidance on federal tax compliance for medical licensees, and whether operators begin filing amended returns claiming prior-year deductions tied to rescheduling approval dates.

Original report: WTOP News ↗
Written by the Cannabis Newz automated newsroom, grounded in the cited news sources, our wire coverage, official license rosters and market filings — every fact is attributed and machine-checked against those sources before publication. Spotted an error? Tell us via your account page.